When was Complete Genomics founded?

Complete Genomics was founded in 2006 and raised its 1st funding round 2 years after it was founded.

Where is Complete Genomics located?

Complete Genomics is headquartered in San Jose, United States. It is registered at San Jose, California.

How many employees does Complete Genomics have?

As of Sep 30, 2026, the latest employee count at Complete Genomics is 237.

Is Complete Genomics a funded company?

Complete Genomics is a funded company, having raised a total of $125M across 4 funding rounds to date. The company's 1st funding round was a $***** Series C round, raised on Mar 31, 2008.

When was the latest funding round of Complete Genomics?

Complete Genomics' latest funding was a $***** Series E round on Aug 19, 2010, with participation from 7 investors.

What is the annual revenue of Complete Genomics?

Annual revenue of Complete Genomics is between $10M and $50M as on Dec 31, 2011

Where does Complete Genomics rank among its competitors?

Complete Genomics ranks 5th amongst 161 active competitors, of which 48 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Nanopore Technologies, which secured $102M in Aug, 2024.

Who are the top competitors of Complete Genomics?

Complete Genomics' top competitors include Nanopore Technologies, Cepheid and PacBio. Among them, Nanopore Technologies secured the most recent funding round in August, 2024.

Complete Genomics - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Complete Genomics is a developer of DNA sequencing platform for human genome sequencing and analysis. It has developed a DNA sequencing platform based on its proprietary DNA nanoball sequencing technology. It is a method of rolling cycle replication to clonally amplify small fragments of DNA into DNA nanoballs which are then attached to a microarray flow cell and sequenced. The sequencing generates fragment lengths of 250-500 bp (mate pair distance), which can then be analyzed using proprietary algorithms. The company's platform is called the Revolocity Platform and is optimized for the Human whole genome and whole exome sequencing. The company also provides analysis and data management software for generating finished variant reports and assemblies.

Website: www.completegenomics.com/
Social
Email ID: *****@completegenomics.com
Phone Number: +1 **********
Registered Address: San Jose, California

Key Metrics

Founded Year

2006

Location

San Jose, United States

Stage

Acquired

Total Funding

$125M in 4 rounds

Latest Funding Round

Series E, Aug 19, 2010, $*****

Investors

Highland Capital Partners & 9 more

Ranked

5^th among 161 active competitors

Annual Revenue

$10M - $50M as on Dec 31, 2011

Employee Count

237 as on Sep 30, 2026

Similar Companies

Nanopore Technologies & 145 more

Exit Details

Acquired by Swiss Rockets (Feb 23, 2026)

View Complete Genomics' full profile

Complete Genomics is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Complete Genomics Inc CIN: 1361103 , United States, Active		$10M - $50M (As on Dec 31, 2011)	-	-
COMPLETE GENOMICS INC. CIN: 203226545 , United States, Active	Dec 26, 999	-	180 (As on Dec 31, 2024)	-

Complete Genomics got acquired by Swiss Rockets on Feb 23, 2026.

Click here to take a look at Complete Genomics's acquisition in detail

Complete Genomics has raised a total funding of $125M over 4 rounds. Its first funding round was on Mar 31, 2008. Its latest funding round was a Series E round on Aug 19, 2010 for $*****. 7 investors participated in its latest round. Complete Genomics has 10 institutional investors.

Here is the list of recent funding rounds of Complete Genomics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 19, 2010	4845131	Series E	5590384	1661311	5800035	1237026
Aug 24, 2009	6852671	Series D	5138114	6356627	4623972	Enterprise Partners Venture Capital & 3 more
Jul 02, 2009	1851032	Series C	1743608	6971100	6581696	6990124

Access funding benchmarks and valuations. Sign up today!

View details of Complete Genomics's funding rounds and investors

The founders of Complete Genomics is Radoje Drmanac. Yongwei Zhang is the CEO of Complete Genomics.

Here are the details of Complete Genomics' key team members:

Radoje Drmanac: Co-Founder & CSO of Complete Genomics.
Contact Info: 1 email address

View details of Complete Genomics's Founder profiles and Board Members

Complete Genomics' employee count trend

Complete Genomics has 237 employees as of Sep 26. Here is Complete Genomics's employee count trend over the years:

Employee count trend for Complete Genomics

Uncover Complete Genomics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Complete Genomics include Nanopore Technologies, Cepheid and PacBio. Here is the list of Top 10 competitors of Complete Genomics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Nanopore Technologies 2005, Oxford (United Kingdom), Public	Manufacturer of portable and benchtop devices for real-time DNA sequencing	$1.34B	IP Group, GIC & 93 others	75/100
2nd	Cepheid 1996, Sunnyvale (United States), Acquired	Developer of molecular diagnostic testing solutions	$19.1M	R H Capital Partners, CampVentures & 14 others	73/100
3rd	PacBio 2004, Menlo Park (United States), Public	Developer of instrument systems and software for real-time sequencing of single-molecules	$410M	Deerfield, Kleiner Perkins & 24 others	72/100
4th	Illumina 1993, San Diego (United States), Public	Developer of technologies for analysis of genetic variation and function	$28M	Chevron Technology Ventures, Dow Chemical Company ... & 32 others	71/100
5th	Complete Genomics 2006, San Jose (United States), Acquired	Developer of DNA sequencing platform for human genome sequencing and analysis	$125M	Enterprise Partners Venture Capital, Orbimed ... & 8 others	66/100
6th	Ultima Genomics 2016, Newark (United States), Series D	Developer of high-throughput NGS instrument for research	$600M	General Atlantic, Khosla Ventures & 8 others	62/100
7th	S2 Genomics 2016, Livermore (United States), Acquired	Developer of automated sample preparation systems for genomics	$16M	Broadoak Capital Partners, RCT & 6 others	59/100
8th	Bionano 2002, San Diego (United States), Public	Provider of genome analysis solutions to researchers and clinicians	$124M	Battelle Ventures, Domain Associates & 17 others	58/100
9th	Singular Genomics 2016, San Diego (United States), Acquired	Provider of next-generation gene sequencing and multi-omics technologies	-	Perceptive Advisors, Domain Associates & 5 others	57/100
10th	Bioskryb 2018, Durham (United States), Seed	Developer of a genome sequencing and amplification system	$11.5M	Anzu Partners, Wilson Sonsini Goodrich & Rosati	55/100